(Reuters) -Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it does not already own for $25.75 apiece, a filing showed on ...
Brookfield emerges as the third suitor for Insignia, also offering A$3.07 billion and sparking a three-way bidding war for the Aussie wealth manager. Copyright 2025 Thomson Reuters.
But one BDC that has been seemingly firing on all cylinders despite the challenging economic backdrop is Bain Capital Specialty Finance (NYSE:BCSF). Over the past year, the BDC has shown some ...
Wells Fargo analyst Finian O’Shea maintained a Buy rating on Bain Capital Specialty Finance (BCSF – Research Report) today and set a price target of $18.00. The company’s shares closed yeste ...
Bain Capital Private Equity proposed to buy the remaining shares of Surgery Partners, an ambulatory surgery center provider in which the private equity firm already has a 39% stake. Under the ...
Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it ...
The company is managed by BCSF Advisors LP, a wholly owned subsidiary of Bain Capital Credit, which is a wholly owned subsidiary of Bain Capital, LP. Rating Sensitivities Given the Stable Outlook ...
from Bain Capital Private Equity, LP (“Bain Capital”) to acquire all of the outstanding shares of Surgery Partners not already owned by Bain Capital for a cash consideration of $25.75 per ...
NEW YORK, January 31, 2025--(BUSINESS WIRE)--KBRA assigns a rating of BBB to Bain Capital Specialty Finance, Inc.'s ("BCSF" or "the company") $350 million, 5.95% senior unsecured notes due 2030.
The company is managed by BCSF Advisors LP, a wholly owned subsidiary of Bain Capital Credit, which is a wholly owned subsidiary of Bain Capital, LP. A description of all substantially material ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
